Dormonoct 2mg Tablet
PDF Leaflet Revision Date: 10 July 2019
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of insomnia and sleep disturbances.
Dosage (summary)
Adults: 1-2 mg at bedtime; Elderly: 0.5-1 mg.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; contraindicated in breastfeeding.
Key Drug Interactions
- Alcohol
- CNS depressants
- Barbiturates
Contraindications
- Hypersensitivity to loprazolam
- Severe respiratory insufficiency
- Myasthenia gravis
- Sleep apnoea syndrome
- Severe hepatic insufficiency
Common side effects
- Drowsiness
- Over-sedation
- Confusion
- Ataxia
Counselling Points
- Take 30 mins before bedtime
- Avoid alcohol
- Do not drive after taking
Serious warnings
- Risk of dependence
- Withdrawal symptoms
- Caution in pulmonary disease
Important Disclaimer
The Dormonoct 2mg Tablet professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
